https://www.biospace.com/oncopeptides-announces-that-new-data-for-melflufen-is-accepted-for-presentation-at-the-annual-american-society-of-hematology-meeting
Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a pharmaceutical company focusing on the development of targeted therapies for difficult-to-treat...
announcesnewdatamelflufenaccepted